Implantable Medical-Grade Primary Lithium Batteries
FDA · FDA OFFICE OF ACQ GRANT SVCS
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75F40126Q00420 in this department, oldest first.
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Implantable Medical-Grade Primary Lithium Batteries � The contractor shall furnish twenty (20) new and unused implantable medical-grade primary lithium batteries of Li/SVO-CFx chemistry, in two configurations of ten (10) units each. No manufacturer, brand, model, or manufacturer part number is specified. Any product meeting every stated salient characteristic is acceptable. Item 1 � High-rate configuration (Qty 10 EA): Rated capacity 1.70 Ah minimum to 1.90 Ah maximum (nominal 1.78 Ah); OCV-BOL 3.15 V minimum to 3.40 V maximum (nominal 3.25 V); capable of pulse discharge with continuous backgr… (show all)
ound load ?95.3 k?, pulse amplitude ?3.0 A, pulse duration 10 seconds, pulse frequency up to once every 150 days, and 2.0 V cutoff. Stainless steel case; negative case polarity; molybdenum or equivalent terminal; hermetically sealed; weight ?17 g; volume ?6.5 cc; approximate dimensions 34.93 mm � 27.94 mm � 6.30 mm and shall not exceed these values by more than 5%; storage temperature �20�C to +60�C. All 10 units shall be from the same manufacturing lot. Item 2 � Medium-rate configuration (Qty 10 EA): Rated capacity 4.80 Ah minimum to 5.00 Ah maximum (nominal 4.92 Ah); OCV-BOL 3.15 V minimum to 3.40 V maximum (nominal 3.25 V); capable of medium-rate sustained discharge with pulsing, background load 9.53 k?, pulse amplitude 20 mA, pulse duration 900 seconds, pulse frequency up to once every 63 days, cutoff voltage 2.0 V minimum, with usable capacity 4.80 Ah to 5.00 Ah between OCV-BOL and cutoff at 37�C. Titanium case; negative case polarity; titanium or equivalent terminal; hermetically sealed; weight ?22 g; volume ?12.5 cc; approximate dimensions 46.48 mm � 31.70 mm � 9.63 mm and shall not exceed these values by more than 5%; operating temperature 37�C nominal; storage temperature �20�C to +60�C. All 10 units shall be from the same manufacturing lot. For both configurations, each battery shall have a minimum of two (2) years remaining from the date of manufacture at delivery. Product documentation shall include battery specifications, safety data sheets (SDS), and other applicable product documentation at no separate charge. Packaging shall follow standard commercial practice and applicable safety and transportation regulations for lithium-based medical-grade components, including applicable DOT and IATA Dangerous Goods Regulations. Lot number and date of manufacture shall be marked on each package. Advance shipping notification shall include carrier, tracking information, and estimated delivery date, and delivery logistics shall be coordinated with the Government POC before shipment. The Government will accept the contractor's standard commercial warranty to the maximum extent practicable. The batteries are passive supply items with no embedded or companion software, no FDA network connection, and no storage or transmission of data. Requirements document is in the solicitation.
Recent Agency Awards (Loose Match)
24 award notices on SAM.gov in the last 24 months. Matched by: Same agency (FDA), any industry: a loose match.
Loose match: same agency, any industry. Read the titles before treating these as competitors.
Single-winner award sizes (24): middle half $402K to $19.1M, median $2.6M; range $82K to $120.8M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| Please_See_Spreadsheet Silver Spring MD 20993 USA | 3 | $153.2M | Oct 8, 2026 |
| DCT, INCORPORATED | 1 | $52.8M | Sep 15, 2026 |
| TRANQUIL CLINICAL AND RESEARCH CONSULTING SERVICES LLC | 1 | $50.0M | Sep 16, 2025 |
| NATI-NVE Support Services, LLC | 1 | $49.0M | May 21, 2026 |
| HARVARD PILGRIM HEALTH CARE INC | 1 | $31.7M | Mar 30, 2026 |
| TOXICOLOGIC PATHOLOGY ASSOCIATES INC | 1 | $26.1M | Sep 15, 2025 |
| IHRC, INCORPORATED | 1 | $14.5M | Sep 16, 2026 |
| VITALANT Scottsdale AZ 85258 USA | 1 | $10.0M | Sep 8, 2025 |
| WE PHARMA, INC. | 1 | $4.0M | Sep 11, 2026 |
| THE BIONETICS CORP | 1 | $2.8M | Jul 21, 2025 |
Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.
- Oct 8, 2026Please_See_Spreadsheet Silver Spring MD 20993 USA$120.8MFY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory ScienceNo listed company matched (Materiality N/A)
- Sep 24, 2026TRADESPACE INC$82KPlatform Subscription to Support Transfer Program Commercial Assessment LeadsNo listed company matched (Materiality N/A)
- Sep 24, 2026TURBOFIL PACKAGING MACHINES, LLC$454KAutomated Vial Capper Machine and Labeler systemNo listed company matched (Materiality N/A)
- Sep 22, 2026ABIDE INTERNATIONAL, INC.$1.8MBuilding Exterior Repair Project � FDA Pacific Southwest LaboratoryNo listed company matched (Materiality N/A)
- Sep 17, 2026LUSARDI CONSTRUCTION CO. San Marcos CA 92078 USA$779KIRV Exhaust and Vacuum Pump ReplacementNo listed company matched (Materiality N/A)
- Sep 16, 2026IHRC, INCORPORATED$14.5MFDA Occupational Safety, Industrial Hygiene, Information Systems, and Training (OSIST) IDIQNo listed company matched (Materiality N/A)
- Sep 15, 2026DCT, INCORPORATED$52.8MNational Center for Toxicological Research (NCTR) on-site facility Operations and Maintenance (O&M) support servicesNo listed company matched (Materiality N/A)
- Sep 11, 2026WE PHARMA, INC.$4.0MPharmaceutical Products for CDER Research Studies - IDIQNo listed company matched (Materiality N/A)
- Aug 31, 2026GOVERNMENT SCIENTIFIC SOURCE INC$399KDigital Slide Scanner SystemNo listed company matched (Materiality N/A)
- Aug 21, 2026Z-SPEC, INC.$123KPost-Award Public NoticeNo listed company matched (Materiality N/A)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
- 0 of their lobbyists list a past Food & Drug Administration (FDA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 129 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.